PBM Compensation 'Delinked' From List Price, Utilization In Medicare Part D Under Senate Bill

Legislation focuses on key aspect of Senate Finance Committee framework for reforming pharmacy benefit managers, reflecting concerns that current compensation practices reward PBMs for higher list prices and increase costs for patients. It does not take direct aim at rebates.

Why Are PBM Fees Based On A Drug's List Price? • Source: Shutterstock

More from Market Access

More from Pink Sheet